Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Capsigen logo — Driven to Evolve

Capsigen

Driven to Evolve

Founded 2020 United States Vancouver, United States 3 employees Seed Biotechnology

General Information

Company Name Capsigen
Founded Year 2020
Location United States Vancouver, United States +1
Employees 3
Industries Biotechnology
Funding Stage Seed
Social

Get notified when Capsigen moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Capsigen

Capsigen is a pioneering biotechnology startup founded in 2020 with the slogan "Driven to Evolve". The company specializes in engineering AAV capsids for gene therapies, with the goal of providing permanent cures for patients suffering from intractable illnesses. Capsigen's approach, which is based on a disease-first strategy, is aimed at ushering in a new era of genetic medicines. Powered by the innovative TRADE™ and data science platforms, the company focuses on engineering vectors with the highest potency and cell-type specificity, ensuring that the genetic medicines developed are tailored to the unique biology of the disease, thereby maximizing patient benefits. The company's last investment was a Seed Round investment at 01 December 2020, with the participation of MP Healthcare Venture Management as the investors. Capsigen is headquartered in the United States. The company's commitment is driven by a goal to fulfill the promise of delivering new cures to millions of patients relying on scientific advancements.

Taxonomy: Gene therapies, AAV capsids, Genetic medicines, Data science platforms, RNA screening, Disease-first approach, Cell-type specificity, Drug development, Precision medicine, Therapeutic engineering, Intractable illness, Biological engineering, Healthcare innovation

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Seed Round •••••• 1
Investor
01 Dec 2020

Capsigen Alternatives & Competitors

Capsigen vs
Kardigan
Kardigan United States

Cardiovascular disease is the leading cause of death in the world. We are developing novel medicine...

198 employees
Capsigen vs
Beam Therapeutics
Beam Therapeutics United States

Our vision is to provide life-long cures for patients suffering from serious diseases.

IPO
597 employees
Biotechnology
Capsigen vs
Locanabio, Inc.
Locanabio, Inc. United States

Creating RNA-targeting gene therapies to treat devastating diseases

Series B
7 employees
Biotechnology, Health Care

FAQ About Capsigen

Driven to Evolve
Capsigen was founded in 2020.
Capsigen is headquartered in Vancouver, United States.
Capsigen operates in the following industries: Biotechnology.
Capsigen has approximately 3 employees.
Capsigen has completed 1 funding round. The latest funding stage is Seed.
Top alternatives and competitors to Capsigen include Kardigan, Beam Therapeutics, Locanabio, Inc., Tome Biosciences, Stylus Medicine. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Capsigen and Kardigan are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Capsigen and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy